Article Details

Vigil Neuroscience Reports Positive Interim Data from Phase 2 IGNITE Proof-of-Concept ...

Retrieved on: 2023-11-17 16:59:40

Tags for this article:

Click the tags to see associated articles and topics

Vigil Neuroscience Reports Positive Interim Data from Phase 2 IGNITE Proof-of-Concept .... View article details on hiswai:

Excerpt

Vigil Neuroscience Reports Positive Interim Data from Phase 2 IGNITE Proof-of-Concept Clinical Trial Evaluating Iluzanebart (VGL101) as a ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo